Skip to main content
. 2018 Oct 26;2018(10):CD007554. doi: 10.1002/14651858.CD007554.pub3

NCT01753154.

Methods
  • Study design: cross‐over RCT

  • Randomisation method: not reported

  • Blinding: open label

  • Intention to treat: unclear

  • Follow‐up period: 16 weeks

Participants
  • Countries: Poland and Spain

  • Setting: multicentre

  • prevalent APD patients

Interventions
  • Balance PD solution for 8 weeks then conventional PD solution for another 8 weeks

Outcomes
  • RRF

  • Peritoneal UF

  • Peritoneal solute clearance

  • fluid status

Notes
  • Study recently completed; no data available